Q3 2020 Sales Performance
Bexsero: leading the market in Meningitis B
gsk
Invasive Meningococcal B
disease
Incidence and serotype distribution varies
by region; most common serogroup is
Men B
Affects healthy infants, children and teens
Invasive Men B mortality rate: ~10%
Dramatic health impact: rapid disease
progression, up to 20% of those who
survive may suffer major physical or
neurological disability
Sales growth driven by global
demand and US share gains
£m
Growing global sales1
127
37
390
584
556
679
Launched in 35 markets
EU: Strong competitive
differentiation with infant
indication: incidence in infants
>10x that in adolescents
(competing product indicated
for adolescent use only)
US: 72% market share of fast
growing MenB market²; infant
indication studies ongoing
1. 2014 and 2015 figures represent 12 month pro forma sales (unaudited).
2. US Men B market grew +22% in 2019.
2014
2015 2016 2017 2018 2019
68
88View entire presentation